國立高雄大學圖資館 |

Language: English

Back

HCVthe journey from discovery to a c...

Sofia, Michael J.

HCVthe journey from discovery to a cure.Volume I /

Record Type:	Electronic resources : Monograph/item
Title/Author:	HCVedited by Michael J. Sofia.
Reminder of title:	the journey from discovery to a cure.
other author:	Sofia, Michael J.
Published:	Cham :Springer International Publishing :2019.
Description:	viii, 463 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
Subject:	Hepatitis CTreatment.
Online resource:	https://doi.org/10.1007/978-3-030-28207-3
ISBN:	9783030282073$q(electronic bk.)

HCVthe journey from discovery to a cure.Volume I /
HCVthe journey from discovery to a cure.Volume I /[electronic resource] :edited by Michael J. Sofia. - Cham :Springer International Publishing :2019. - viii, 463 p. :ill., digital ;24 cm. - Topics in medicinal chemistry,311862-2461 ;. - Topics in medicinal chemistry ;8..

Identification of the virus, the medical need and clearing the blood supply -- Mapping the HCV genome -- The molecular virology of HCV -- The development of the HCV replicon system -- The Evolution of IFN therapy for HCV -- Evolution of HCV NS5B Non-Nucleoside Inhibitors -- Evolution of HCV NS5B Nucleoside & Nucleotide Inhibitors -- Discovery and Development of Sofosbuvir -- Discovery of Beclabuvir -- Discovery of Dasabuvir -- Evolution of HCV NS3/4 protease inhibitors -- Discovery and Development of Telaprevir -- Discovery and Development of Boceprevir -- Discovery and Development of Asunaprevir -- Discovery and Development of Grazoprevir -- Discovery and Development of Simeprevir -- Discovery and Development of Paritaprevir & Glecaprevir.

Hepatitis C is a liver disease caused by the hepatitis C virus (HCV) and infects approximately 75 million individuals worldwide. It is also one of the major causes of liver cancer and liver transplants. The elucidation of the HCV genome, and the development of a whole cell system to study the virus spurred the search for novel direct acting antiviral drugs to cure this disease. This global effort culminated in the development of direct acting antiviral drugs that led to cure rates approaching 100% in all patient populations after only 8-12 weeks of therapy. These efforts resulted in one of the greatest achievements in public health and provides the potential for eliminating HCV as a major disease worldwide. This volume is aimed at a broad audience of academic and industrial scientists interested in the discovery and development of drugs to treat viral diseases and those interested in reading about one of the most unique accomplishments in biomedical research. The volume will provide a one of a kind reference work that highlights the many efforts, from the discovery of the HCV virus, to the invention of breakthrough medicines and their use in the real world to cure patients. It is the companion book to the volume "HCV: The Journey from Discovery to a Cure - Volume II".

ISBN: 9783030282073$q(electronic bk.)

Standard No.: 10.1007/978-3-030-28207-3doiSubjects--Topical Terms:

558961
Hepatitis C
--Treatment.

LC Class. No.: RC848.H425 / H388 2019

Dewey Class. No.: 616.3623

HCVthe journey from discovery to a cure.Volume I /
LDR:03095nmm a2200337 a 4500 001 569333
003 DE-He213
005 20200206132907.0
006 m d
007 cr nn 008maaau
008 200723s2019 sz s 0 eng d
020 $a 9783030282073$q(electronic bk.)
020 $a 9783030282066$q(paper)
024 7 $a 10.1007/978-3-030-28207-3 $2 doi
035 $a 978-3-030-28207-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RC848.H425 $b H388 2019
072 7 $a PSB $2 bicssc
072 7 $a SCI013020 $2 bisacsh
072 7 $a PSB $2 thema
082 0 4 $a 616.3623 $2 23
090 $a RC848.H425 $b H431 2019
245 0 0 $a HCV $h [electronic resource] : $b the journey from discovery to a cure. $n Volume I / $c edited by Michael J. Sofia.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a viii, 463 p. : $b ill., digital ; $c 24 cm.
490 1 $a Topics in medicinal chemistry, $x 1862-2461 ; $v 31
505 0 $a Identification of the virus, the medical need and clearing the blood supply -- Mapping the HCV genome -- The molecular virology of HCV -- The development of the HCV replicon system -- The Evolution of IFN therapy for HCV -- Evolution of HCV NS5B Non-Nucleoside Inhibitors -- Evolution of HCV NS5B Nucleoside & Nucleotide Inhibitors -- Discovery and Development of Sofosbuvir -- Discovery of Beclabuvir -- Discovery of Dasabuvir -- Evolution of HCV NS3/4 protease inhibitors -- Discovery and Development of Telaprevir -- Discovery and Development of Boceprevir -- Discovery and Development of Asunaprevir -- Discovery and Development of Grazoprevir -- Discovery and Development of Simeprevir -- Discovery and Development of Paritaprevir & Glecaprevir.
520 $a Hepatitis C is a liver disease caused by the hepatitis C virus (HCV) and infects approximately 75 million individuals worldwide. It is also one of the major causes of liver cancer and liver transplants. The elucidation of the HCV genome, and the development of a whole cell system to study the virus spurred the search for novel direct acting antiviral drugs to cure this disease. This global effort culminated in the development of direct acting antiviral drugs that led to cure rates approaching 100% in all patient populations after only 8-12 weeks of therapy. These efforts resulted in one of the greatest achievements in public health and provides the potential for eliminating HCV as a major disease worldwide. This volume is aimed at a broad audience of academic and industrial scientists interested in the discovery and development of drugs to treat viral diseases and those interested in reading about one of the most unique accomplishments in biomedical research. The volume will provide a one of a kind reference work that highlights the many efforts, from the discovery of the HCV virus, to the invention of breakthrough medicines and their use in the real world to cure patients. It is the companion book to the volume "HCV: The Journey from Discovery to a Cure - Volume II".
650 0 $a Hepatitis C $x Treatment. $3 558961
650 0 $a Hepatitis C virus. $3 274259
650 1 4 $a Medicinal Chemistry. $3 275183
650 2 4 $a Virology. $3 196498
650 2 4 $a Medical Biochemistry. $3 274286
650 2 4 $a Bioorganic Chemistry. $3 275016
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
700 1 $a Sofia, Michael J. $3 855300
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Topics in medicinal chemistry ; $v 8. $3 567153
856 4 0 $u https://doi.org/10.1007/978-3-030-28207-3
950 $a Chemistry and Materials Science (Springer-11644)